Antibody–Drug Conjugates Reshape Solid Tumor Therapy Amid Safety and Target Challenges
A new review in Holistic Integrative Oncology charts the rapid rise of antibody–drug conjugates in solid tumors while detailing the ...
A new review in Holistic Integrative Oncology charts the rapid rise of antibody–drug conjugates in solid tumors while detailing the ...
A multi-stakeholder study finds that current patient-reported outcome measures fail to capture the full side-effect burden and emotional strain of ...
A sweeping new review in Molecular Cancer maps the PD-1/PD-L1 axis from immune evasion mechanisms to next-generation therapeutics, offering a ...
A comprehensive Molecular Cancer review explains how antibody-drug conjugates deliver lethal payloads to tumors, why resistance emerges, and which next-generation ...
A new Research Topic in Frontiers in Hematology highlights epigenetic targets, immunotherapy combinations, resistance mechanisms, and prognostic models driving personalized ...
Researchers have engineered mRNA-delivered bispecific antibodies derived from llama candidates that neutralize a broad range of SARS-CoV-2 variants and protected ...
A new review in Molecular Biology Reports maps how checkpoint inhibitors, engineered cell therapies, and emerging immunotherapies are transforming treatment ...
A new review charts how immune cell engagers, from bispecific antibodies and aptamers to surface-engineered cells and nanoparticles, are being ...
A new review argues that antibody–drug conjugates act as immune modulators through immunogenic cell death, Fc-mediated effector functions and tumour ...
A new review in Annals of Hematology details how molecular profiling and a growing arsenal of targeted and immune-based therapies ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine